Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Price Negotiation Surfaces Again? IMAC Proposal Needs Close Read

Executive Summary

The Obama administration's proposal to establish an executive branch advisory council on Medicare payment issues may raise the threat of government negotiations for Medicare Part D drug prices

You may also be interested in...



IMAC Absent From Energy & Commerce Reform Bill; White House Still Pushing

Health reform legislation emerging from the House Energy and Commerce Committee does not include a provision establishing a new executive branch agency to guide Medicare payment policy and reform - despite earlier statements from committee Chairman Henry Waxman, D-Calif., indicating it would

IMAC Absent From Energy & Commerce Reform Bill; White House Still Pushing

Health reform legislation emerging from the House Energy and Commerce Committee does not include a provision establishing a new executive branch agency to guide Medicare payment policy and reform - despite earlier statements from committee Chairman Henry Waxman, D-Calif., indicating it would

Dollars For Donuts: PhRMA's $80 Bil. Coup In Health Care Reform

PhRMA's commitment to contribute $80 billion toward health systems savings over the next 10 years looks like an important tactical win for the brand name industry entering the critical phase of the health reform debate

Topics

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel